Nurturing the Industry

In a special opinion piece to the Sacramento Bee, outgoing California Healthcare Institute (CHI) CEO (re: BayBio-CHI to merge into CBI)  Todd E. Gillenwater  talks about the importance of the state nurturing the biotech industry. An excerpt: "In 2013, more than 2,600 life sciences companies employed 270,000 people, with average annual wages that topped $100,000, according to this year’s [...]

December 10th, 2014|

Boom in California’s Biomedical Industry

California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry From press release: “California leads the nation in the biomedical industry, supporting highly skilled and well-paying jobs in communities across the state,” said California Governor Jerry Brown. “I look forward to continuing to work with leaders from companies and research institutions throughout the state [...]

November 23rd, 2014|

Tariff Deal Could be Big for San Diego Biotech Companies

From UT-San Diego: "From biotechnology to life sciences to the wireless industry, San Diego companies have much to gain from a newly announced trade breakthrough between the United States and China. On Tuesday, the international business world buzzed about an Information Technology Agreement announced in Beijing that, if ratified, would eliminate roughly $1 trillion in [...]

November 17th, 2014|

CIRM: Where the Money Has Gone

In a recent blogpost, CIRM outlines how its Proposition 71 money for stem cell research is being utilized: "Of the $3 billion Prop 71 generates around $2.75 billion was set aside to be awarded to research, build laboratories etc. The rest was earmarked for things such as staff and administration to help oversee the funding [...]

November 6th, 2014|

San Diego’s Venture Capital Problem?

Voice of San Diego has a feature with interactive graphics that show San Diego's venture capital activity. In the feature, Lisa Halverstadt details how "tech startup founders in San Diego often lament the difficulties of raising money in San Diego" -- but how the biotech industry has seen great numbers: "Biotech is the big exception when it [...]

October 24th, 2014|

Raising Money for Ebola Research Through Crowdfunding

Fox5 San Diego has a feature and video on its website about how Erica Ollman Saphire, a professor in the department of immunology and microbial science at Scripps, placed an appeal on the website in hopes of raising $100,000 to supplement funding from the federal government for Ebola research. An excerpt: "At a recent seminar at [...]

October 14th, 2014|

Life Sciences – Primed For Job Growth

Jonathan Horn at UT-San Diego has written a feature about different industry sectors primed for job growth in the area - #1 mentioned was life sciences: "Most of the openings are expected to be for research associates or assistants, medical lab technicians or clinical lab scientists, lab assistants, and sales reps. Employers experience the most difficulty [...]

October 5th, 2014|

$20M to Launch 2 Biotechs in San Diego

From Bruce Bigelow at Xconomy: "San Diego’s Avalon Ventures is taking the wraps off two new startups, with each one getting as much as $10 million in Series A financing through the partnership that Avalon established early last year with GlaxoSmithKline. Silarus Therapeutics is targeting a recently discovered hormone, erythroferrone, for treating disorders involving iron [...]

September 25th, 2014|

Big Biocluster Leasing Activity

  A recent JLL blog post describes how the biotech leasing activity has been huge in the San Diego biocluster region, saying that it's the largest level of activity in over a decade. An excerpt: "Demand drivers during 2014 have been a hot IPO market that has seen 12 San Diego companies go public since [...]

September 3rd, 2014|

Batu Biologics’ Successful Crowdfunding Campaign

From Crowdfund Insider: "Using a fundraising approach seldom seen in the life sciences sector, Batu Biologics, an immunotherapy company working to develop the first anti-angiogenic cancer vaccine, has successfully raised $100,000 through crowdfunding giant, Indiegogo. Batu Biologics launched the crowdfunding campaign in June 2014 to fund the completion of preclinical studies to support the FDA submission of [...]

August 20th, 2014|

Otonomy “Hears Wall Street Ovation”

Several media outlets covered Otonomy's big recent IPO - some headlines and links:   Xconomy: Otonomy Hears Wall Street Ovation as Some Life Sciences IPOs Dim More FierceBiotech: Ear disease biotech Otonomy bags $100M in a booming IPO More ABC News: Otonomy Shares Rise After IPO Raises $100M More

August 14th, 2014|

Wooing the Big Bucks

UT-San Diego has a great feature about Scripps Research's (and Sanford's and other institutions') attempts to get funding. The article goes into the various paths to get huge philanthropic gifts and the importance of building relationships. The intro: "As The Scripps Research Institute has discovered, being a prestigious biomedical research center doesn’t necessarily bring financial security. La Jolla-based Scripps Research faces increased [...]

August 6th, 2014|

The Duane Roth Legacy Foundation

From U-T San Diego: "La Jolla technology leader and philanthropist Duane Roth was known for bringing together people and ideas. Now, a group of Roth’s friends, family and colleagues are gathering to disburse the first of $120,000 in annual grants they’ve raised in his name. Their goal is to carry on in perpetuity the good [...]

August 3rd, 2014|

Breaking through the Sequencing Bottleneck

From The Burrill Report: "The rapid decline in the cost of genome sequencing is creating an information technology bottleneck as servers designed for general purposes have proven a bit clunky at assembling and analyzing the output from sequencers. Edico Genome thinks it has an answer with its DRAGEN Bio-IT Processor, designed specifically for processing genomic [...]

July 28th, 2014|

Top-Paid Research Institute Professionals of 2014

In a recent "The Lists" feature, Genetic Engineering & Biotechnology News provides the 20 top-paid leaders at research institutes -- and San Diego is a very popular place. On the list: #17. Mitchell Kronenberg, Ph.D., Institution: La Jolla Institute for Allergy and Immunology #16. Richard A. Houghten, Ph.D., Institution: Torrey Pines Institute for Molecular Studies [...]

July 22nd, 2014|

Who Needs Biotech VCs, Anyway?

Alex Lash at Xconomy has an excellent article out that's relevant for all Big3Bio Financial Spotlights: "Who Needs Biotech VCs, Anyway?" The feature contains companies and people from each "Big 3" region, and the signs, statistics, and opinions on the current state of venture capital in biotech as well as new alternatives that have risen recently. An excerpt: [...]

July 16th, 2014|

BIO 2014 = $56 Million for San Diego

From Times of San Diego: "The four-day BIO International Convention ending June 26 “was expected to bring more than $56.3 million to San Diego’s regional economy,” a spokeswoman for the event said (last) Monday. Hosted by the Biotechnology Industry Organization, the San Diego Convention Center event drew 15,667 people from all 50 states and some 70 [...]

July 14th, 2014|

Seragon Purchased for up to $1.7 Billion

Big financial news hit right before the July 4th holiday as Seragan Pharmaceuticals was bought by Genentech, possibly for a whopping $1.7 billion. From Bradley Fikes, UT-San Diego: "In a powerful example of San Diego's biotech innovation ecosystem at work, Seragon Pharmaceuticals, a developer of drugs for cancers that resist estrogen deprivation therapy, is being purchased by [...]

July 7th, 2014|

Hillary Clinton: We Can’t Afford to Lose Biotechs

From NBC San Diego: "The United States could start losing biotechnology companies if the system doesn’t change, former Secretary of State Hillary Rodham Clinton said. The former First Lady made the remarks during the keynote presentation Tuesday at the 2014 BIO International Convention in San Diego. “I don’t want to see biotech companies or pharma companies moving [...]

June 26th, 2014|